Literature DB >> 10889529

Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses.

A Serretti1, E Lattuada, C Lorenzi, R Lilli, E Smeraldi.   

Abstract

The D2 receptor (DRD2) is a binding site of many psychoactive drugs and it has been proposed as a genetic risk factor for psychiatric disorders. The aim of this investigation was to study the DRD2 S311C variant in major psychoses. We studied 1182 inpatients with diagnoses of bipolar disorder (n = 480), major depressive disorder (n = 269), schizophrenia (n = 366), delusional disorder (n = 44), psychotic disorder not otherwise specified (n = 23) and 267 healthy controls. Eight hundred and eighty-seven subjects were also scored for their lifetime symptomatology using the the Operational Criteria checklist for psychotic illness (OPCRIT). DRD2 variants were not associated with affected subjects even when possible confounders like gender and onset were considered. When we considered the 887 subjects with the symptomatologic analysis, we observed a significant association of the DRD2 S311C variant with both delusion and disorganization features. The association was present independently from diagnoses. Our results do not show that coding variants of the DRD2 S311C play a major role in conferring susceptibility to major psychoses, but they may be connected with disorganized and delusional symptomatology independently from diagnoses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889529     DOI: 10.1038/sj.mp.4000726

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  10 in total

1.  Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.

Authors:  Marco Colizzi; Conrad Iyegbe; John Powell; Gianluca Ursini; Annamaria Porcelli; Aurora Bonvino; Paolo Taurisano; Raffaella Romano; Rita Masellis; Giuseppe Blasi; Craig Morgan; Katherine Aitchison; Valeria Mondelli; Sonija Luzi; Anna Kolliakou; Anthony David; Robin M Murray; Alessandro Bertolino; Marta Di Forti
Journal:  Schizophr Bull       Date:  2015-03-31       Impact factor: 9.306

Review 2.  Molecular genetics of the psychosis phenotype.

Authors:  Pamela DeRosse; Anil K Malhotra; Todd Lencz
Journal:  Can J Psychiatry       Date:  2012-07       Impact factor: 4.356

3.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Authors:  Stephen J Glatt; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

4.  The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia.

Authors:  Pamela DeRosse; Todd Lencz; Katherine E Burdick; Samuel G Siris; John M Kane; Anil K Malhotra
Journal:  Schizophr Bull       Date:  2008-07-15       Impact factor: 9.306

Review 5.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

6.  Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness.

Authors:  T Bernard Bigdeli; Brion S Maher; Zhongming Zhao; Edwin J C G van den Oord; Dawn L Thiselton; Jingchun Sun; Bradley T Webb; Richard L Amdur; Brandon Wormley; Francis A O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler; Ayman H Fanous
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

7.  Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

Authors:  Kenneth Blum; Amanda L C Chen; Marlene Oscar-Berman; Thomas J H Chen; Joel Lubar; Nancy White; Judith Lubar; Abdalla Bowirrat; Eric Braverman; John Schoolfield; Roger L Waite; Bernard W Downs; Margaret Madigan; David E Comings; Caroline Davis; Mallory M Kerner; Jennifer Knopf; Tomas Palomo; John J Giordano; Siobhan A Morse; Frank Fornari; Debmalya Barh; John Femino; John A Bailey
Journal:  Int J Environ Res Public Health       Date:  2011-11-29       Impact factor: 3.390

8.  Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Authors:  Beatriz Camarena; Ana Fresán; Alejandro Aguilar; Raúl Escamilla; Ricardo Saracco; Jorge Palacios; Alfonso Tovilla; Humberto Nicolini
Journal:  ISRN Psychiatry       Date:  2012-04-19

9.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759

Review 10.  The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Alma Genis-Mendoza; Mariela Alpuin-Reyes
Journal:  Behav Brain Funct       Date:  2016-11-09       Impact factor: 3.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.